Green Matters on MSN3mon
Neffy, the Needle-Free Alternative to EpiPen, Earns FDA Approval — Here's What It Will Cost YouIt sounds like this is something that's resonating with investors, since the company's stock (NASDAQ symbol SPRY) has more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback